MyFinsight
Home
Blog
About
Available-for-sale securities
$218,284K
(68.98%↑ Y/Y)
Cash and cash
equivalents
$159,394K
(14.73%↑ Y/Y)
Prepaid expenses and
other current assets
$16,792K
(59.47%↑ Y/Y)
Restricted cash, current
$638K
Operating lease,
right-of-use assets
$20,667K
(-10.66%↓ Y/Y)
Property and equipment,
net
$3,959K
(-8.29%↓ Y/Y)
Restricted cash, net of
current portion
$708K
(-63.20%↓ Y/Y)
Other non-current
assets
$138K
(-50.36%↓ Y/Y)
Total current assets
$395,108K
(41.80%↑ Y/Y)
Total non-current
assets
$25,472K
(-14.10%↓ Y/Y)
Total assets
$420,580K
(36.42%↑ Y/Y)
Total liabilities and
stockholders equity
$420,580K
(36.42%↑ Y/Y)
Total stockholders
equity
$374,075K
(44.83%↑ Y/Y)
Total liabilities
$46,505K
(-6.99%↓ Y/Y)
Accumulated deficit
-$1,069,311K
(-24.02%↓ Y/Y)
Accumulated other
comprehensive income
-$113K
(-197.37%↓ Y/Y)
Additional paid-in capital
$1,443,394K
(28.82%↑ Y/Y)
Total current
liabilities
$28,584K
(-4.23%↓ Y/Y)
Total non-current
liabilities
$17,921K
(-11.08%↓ Y/Y)
Common stock, 0.001 par
value 480,000,000 and...
$105K
(34.62%↑ Y/Y)
Accrued expenses and
other current...
$17,790K
(7.52%↑ Y/Y)
Accounts payable
$4,360K
(-7.31%↓ Y/Y)
Derivative liabilities
$4,200K
(-26.32%↓ Y/Y)
Operating lease
liabilities, current
$2,234K
(14.98%↑ Y/Y)
Operating lease
liabilities, net of current...
$17,921K
(-11.08%↓ Y/Y)
Back
Back
Balance Sheet
Solid Biosciences Inc. (SLDB)
Solid Biosciences Inc. (SLDB)
source: myfinsight.com